Riassunto Gli ultimi dati su Tafasitamab di Incyte allASH 2024 dimostrano una sopravvivenza libera da progressione significativamente migliorata in pazienti affetti da linfoma follicolare recidivante o refrattario
IMCGX Fund | USD 10.65 0.16 1.53% |
Slightly above 53% of Transamerica Mid's investors are presently thinking to get in. The analysis of overall sentiment of trading Transamerica Mid Cap mutual fund suggests that some investors are interested at this time. Transamerica Mid's investing sentiment can be driven by a variety of factors including economic data, Transamerica Mid's earnings reports, geopolitical events, and overall market trends.
Transamerica |
Incyte oggi ha annunciato ulteriori risultati provenienti dal trial pivotale di fase 3 inMIND volto a valutare la terapia a base di tafa
Read at businesswire.com
Transamerica Mid Fundamental Analysis
We analyze Transamerica Mid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Transamerica Mid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Transamerica Mid based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Transamerica Mid is currently under evaluation in price to sales among similar funds. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Transamerica Mid Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Transamerica Mid mutual fund to make a market-neutral strategy. Peer analysis of Transamerica Mid could also be used in its relative valuation, which is a method of valuing Transamerica Mid by comparing valuation metrics with similar companies.
Peers
Transamerica Mid Related Equities
TFAGX | Tfa Alphagen | 1.37 | ||||
CDGCX | Crafword Dividend | 0.89 | ||||
FGTZX | Ftfa Franklin | 0.78 | ||||
HSUAX | Rational Defensive | 0.72 | ||||
PQUAX | Pace Smallmedium | 0.70 | ||||
FRAAX | Franklin Growth | 7.35 |
Other Information on Investing in Transamerica Mutual Fund
Transamerica Mid financial ratios help investors to determine whether Transamerica Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transamerica with respect to the benefits of owning Transamerica Mid security.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |